Renalytix Statistics
Renalytix (RENXF) Stock Statistics & Valuation Metrics
Total Valuation
Renalytix has a market cap or net worth of $48.08M. The enterprise value is $13.29M.
- Market Cap
- $48.08M
- Enterprise Value
- $13.29M
Share Statistics
Renalytix has 670,459,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 670,459,350
- Owned by Insiders
- 3.73%
- Owned by Institutions
- 0.02%
Financial Efficiency
Renalytix’s return on equity (ROE) is 2.25 and return on invested capital (ROIC) is 2247.91%.
- Return on Equity (ROE)
- 2.25
- Return on Assets (ROA)
- -3.08
- Return on Invested Capital (ROIC)
- 2247.91%
- Return on Capital Employed (ROCE)
- 17.45
- Revenue Per Employee
- 65.38K
- Profits Per Employee
- -309.47K
- Employee Count
- 46
- Asset Turnover
- 0.65
- Inventory Turnover
- 3.79
Valuation Ratios
The current PE Ratio of Renalytix is -3.38. Renalytix’s PEG ratio is -0.04.
- PE Ratio
- -3.38
- PS Ratio
- 30.04
- PB Ratio
- -22.85
- Price to FCF
- -8.74
- Price to Operating Cash Flow
- -5.08
- PEG Ratio
- -0.04
Income Statement
In the last 12 months, Renalytix had revenue of 3.01M and earned -14.24M in profits. Earnings per share was -0.03.
- Revenue
- 3.01M
- Gross Profit
- 1.10M
- Operating Income
- -14.03M
- Pretax Income
- -14.74M
- Net Income
- -14.24M
- EBITDA
- -13.83M
- Earnings Per Share (EPS)
- -0.03
Cash Flow
In the last 12 months, operating cash flow was -5.40M and capital expenditures -100,000, giving a free cash flow of -5.50M billion.
- Operating Cash Flow
- -5.40M
- Free Cash Flow
- -5.50M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Renalytix pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -11.44%
- Earnings Yield
- -29.54%
Stock Price Statistics
- Beta
- 0.84
- 52-Week Price Change
- -20.78%
- 50-Day Moving Average
- 0.06
- 200-Day Moving Average
- 0.05
- Relative Strength Index (RSI)
- 99.50
- Average Volume (3m)
- ―
Important Dates
Renalytix upcoming earnings date is Dec 08, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Oct 28, 2026
- Next Earnings Date
- Dec 08, 2026
- Ex-Dividend Date
- ―
Financial Position
Renalytix as a current ratio of 0.61, with Debt / Equity ratio of -90.48%
- Current Ratio
- 0.61
- Quick Ratio
- 0.52
- Debt to Market Cap
- 0.39
- Net Debt to EBITDA
- -0.31
- Interest Coverage Ratio
- -23.33
Taxes
In the past 12 months, Renalytix has paid -501.25K in taxes.
- Income Tax
- -501.25K
- Effective Tax Rate
- 0.03
Enterprise Valuation
Renalytix EV to EBITDA ratio is 0.00, with an EV/FCF ratio of -8.68.
- EV to Sales
- 29.85
- EV to EBITDA
- 0.00
- EV to Free Cash Flow
- -8.68
- EV to Operating Cash Flow
- -8.84
Balance Sheet
Renalytix has $6.20M in cash and marketable securities with $5.80M in debt, giving a net cash position of $400.00K billion.
- Cash & Marketable Securities
- $6.20M
- Total Debt
- $5.80M
- Net Cash
- $400.00K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 50.00%, with operating margin of -443.75%, and net profit margin of -506.25%.
- Gross Margin
- 50.00%
- Operating Margin
- -443.75%
- Pretax Margin
- -506.25%
- Net Profit Margin
- -506.25%
- EBITDA Margin
- 0.00%
- EBIT Margin
- -437.50%
